Sage Journals: Discover world-class research

Free access

Editorial

First published 2012-1

The Withdrawal of Xigris

Saxon Ridley, Duncan LA Wyncoll

Journal of the Intensive Care Society

Retricted access

Editorial

First published 2011-12

The Last Xigris ® * Survivor

Philip S. Barie

Surgical Infections

Retricted access

Research article

First published 2012-02

Lilly Withdraws Xigris;Says Evidence of Efficacy Insufficient

Biotechnology Law Report

Retricted access

Research article

First published 2008-10

Bleeding Complications with Drotrecogin Alfa Activated (Xigris ® ): A Retrospective Review of 31 Operative and 68 Non-Operative Patients with Severe Sepsis

Benedict J.W. Taylor, Sarah J. Lee, Kenneth Waxman

The American Surgeon™

Retricted access

Other

First published 2005-12

Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: the first case reported

G F de Larrañaga, G I Remondino, R R Forastiero [...]

Lupus

Retricted access

Other

First published 2003-11

Disease Management vs Drug Management: Directing Drotrecogin Alfa Therapy with Standing Orders for Severe Sepsis

Jennifer Nazworthy, Mark Woods

Hospital Pharmacy

Retricted access

Article commentary

First published 2012-11

Stopping Trials Early for Benefit—Not So Fast!

Andrew C Faust, Tammy Chung, Mark Feldman

Annals of Pharmacotherapy

Retricted access

Review article

First published 2008-09

Use of Drotrecogin Alfa in Necrotizing Fasciitis: A Case Report and Pharmacologic Review

Christopher M. Bland, James D. Frizzi, Angel Reyes

Journal of Intensive Care Medicine

Retricted access

Research article

First published 2010-10

The Use of Drotrecogin Alpha for Necrotizing Soft Tissue Infections

David K. Rosing, Sarath Malepati, Arezou Yaghoubian [...]

The American Surgeon™

Search results